Does Family History of Cancer Influence Undergoing Screening and Gastrointestinal Investigations?


Journal

Journal of gastrointestinal and liver diseases : JGLD
ISSN: 1842-1121
Titre abrégé: J Gastrointestin Liver Dis
Pays: Romania
ID NLM: 101272825

Informations de publication

Date de publication:
27 Oct 2020
Historique:
pubmed: 30 10 2020
medline: 13 10 2021
entrez: 29 10 2020
Statut: epublish

Résumé

Although a family history of cancer (FHC) can modify the lifestyle and attitudes towards participation in cancer screening programs, studies on this relationship show mixed results and vary across populations. The objectives of the study were to compare sociodemographic characteristics, history of gastrointestinal (GI) investigations and Helicobacter pylori eradication, and modifiable cancer risk factors between those with FHC and those with no FHC (NFHC), and to investigate the association between FHC and a history of GI investigations. A total of 3,455 questionnaires from the pilot study of the "Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality (GISTAR study)" in Latvia were analysed. We compared sociodemographic characteristics and history of GI investigations between participants with self- reported FHC and NFHC. Binary logistic regression models adjusted for socio-demographic characteristics and modifiable cancer risk factors were built for a FHC and each GI investigation. Participants with a FHC were more likely to be women, have a higher education and less likely to have harmful habits (smoking, alcohol consumption) than those with NFHC. Participants with a FHC were approximately twice as likely to report recent colorectal investigations specifically for screening, than those with NFHC. In fully adjusted logistic regression models, FHC was significantly associated with a recent history of faecal occult blood tests (FOBTs), colonoscopies, and colorectal investigations (FOBT or colonoscopy) specifically for screening as part of the national organized screening programme. Our results indicate that those with a FHC have different patterns of health-related behaviour than those with NFHC.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Although a family history of cancer (FHC) can modify the lifestyle and attitudes towards participation in cancer screening programs, studies on this relationship show mixed results and vary across populations. The objectives of the study were to compare sociodemographic characteristics, history of gastrointestinal (GI) investigations and Helicobacter pylori eradication, and modifiable cancer risk factors between those with FHC and those with no FHC (NFHC), and to investigate the association between FHC and a history of GI investigations.
METHODS METHODS
A total of 3,455 questionnaires from the pilot study of the "Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality (GISTAR study)" in Latvia were analysed. We compared sociodemographic characteristics and history of GI investigations between participants with self- reported FHC and NFHC. Binary logistic regression models adjusted for socio-demographic characteristics and modifiable cancer risk factors were built for a FHC and each GI investigation.
RESULTS RESULTS
Participants with a FHC were more likely to be women, have a higher education and less likely to have harmful habits (smoking, alcohol consumption) than those with NFHC. Participants with a FHC were approximately twice as likely to report recent colorectal investigations specifically for screening, than those with NFHC. In fully adjusted logistic regression models, FHC was significantly associated with a recent history of faecal occult blood tests (FOBTs), colonoscopies, and colorectal investigations (FOBT or colonoscopy) specifically for screening as part of the national organized screening programme.
CONCLUSION CONCLUSIONS
Our results indicate that those with a FHC have different patterns of health-related behaviour than those with NFHC.

Identifiants

pubmed: 33118535
doi: 10.15403/jgld-813
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

523-528

Commentaires et corrections

Type : CommentIn

Auteurs

Danute Razuka-Ebela (D)

Faculty of Medicine, University of Latvia; Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia. d.razuka.ebela@gmail.com.

Irisa Zile (I)

Faculty of Medicine, University of Latvia, Riga, Latvia. irisa.zile@inbox.lv.

Lilian Tzivian (L)

Faculty of Medicine, University of Latvia; Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia; Holon Institute of Technology, Holon, Israel. liliana.tz@gmail.com.

Inguna Ebela (I)

Faculty of Medicine, University of Latvia, Riga, Latvia. inguna.ebela@gmail.com.

Inese Polaka (I)

Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia. inese.polaka@gmail.com.

Sergei Parshutin (S)

Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia. sergejs.parsutins@lu.lv.

Daiga Santare (D)

Faculty of Medicine, University of Latvia; Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia. daiga.santare@lu.lv.

Raul Murillo (R)

Hospital Universitario San Ignacio, Bogota, Columbia. raulhmurillo@yahoo.com.

Rolando Herrero (R)

International Agency for Research on Cancer, Lyon, France; Agencia Costarricense de Investigaciones Biomédicas, Costa Rica. HerreroR@iarc.fr.

Jin Young Park (J)

International Agency for Research on Cancer, Lyon, France. ParkJY@iarc.fr.

Marcis Leja (M)

Faculty of Medicine, University of Latvia; Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia. marcis.leja@lu.lv.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH